Searchable abstracts of presentations at key conferences in endocrinology

ea0045cme1 | CME Training Day | BSPED2016

GH deficiency vs GH insensitivity

Storr Helen

A wide range of disorders must be considered when assessing a child with Short stature (SS). The growth hormone (GH)-IGF-1 axis is essential for normal foetal and childhood growth and defects at many points in the axis will result in growth impairment leading to childhood and adult SS. Severe SS causes physical and psychological disadvantages and the underlying defects may be associated with increased morbidity. Comprehensive investigation of patients with abnormal auxology sh...

ea0085cme3.1 | CME Symposium 3 | BSPED2022

Genetic approach to Short stature

Storr Helen

Children referred to paediatric endocrinology clinics have variable degrees of short stature and growth failure. There is a wide range of potential aetiologies ranging from normality to an abnormal growth pattern which will lead to adult height below the target height range. Early investigation and diagnosis of short stature is important to prevent delays in the access to appropriate therapies which will improve final height. Genetic variants impacting cellular pathways, hormo...

ea0055wf3 | Workshop F: Disorders of the gonads | SFEEU2018

Honesty is always best

Hussain Shazia , Storr Helen , Drake William

A three year old boy was referred for surgical correction of an undescended right testis. Intra-operatively he was found to have a hyperplastic right gonad which was in continuation with a unilateral fallopian tube, prompting analysis of his karyotype. This showed 46XX/XY mosaicism with 88% of the cells being XX and 12% XY. The post-operative histology confirmed mixed testicular and ovarian tissue in the right gonad. He appeared phenotypically male and had blaschko lines consi...

ea0030oc2.2 | Oral Communications 2 | BSPED2012

Deficiency of the triple A syndrome gene product, ALADIN, renders human adrenal cells susceptible to oxidative stress with subsequent impact on steroidogenesis

Prasad Rathi , Clark Adrian , Storr Helen

Background: Triple A syndrome is a rare, autosomal recessive cause of adrenal insufficiency. Additional features include alacrima, achalasia of the oesophageal cardia, and neurodegenerative disease in 60%. The AAAS gene product is the nuclear pore complex protein ALADIN of unknown function. AAAS patient dermal fibroblasts have been described as hypersensitive to oxidative stress1,2,3.Objective: To establish a better disease model by kno...

ea0028p310 | Steroids | SFEBES2012

Oxidative stress in the pathogenesis of triple a syndrome

Prasad Rathi , Clark Adrian , Storr Helen

Background: Triple A Syndrome is a rare, autosomal recessive cause of adrenal failure that usually manifests in the first decade. Most cases have isolated glucocorticoid deficiency, but this is accompanied by mineralocorticoid deficiency in approximately 10% of cases. Additional features include alacrima (~90%), achalasia of the oesophageal cardia (~75%), and a progressive neurodegenerative process (~60%). The AAAS gene product is the nuclear pore complex protein ALADIN...

ea0027p31 | (1) | BSPED2011

Oxidative stress in the pathogenesis of Triple A syndrome

Prasad Rathi , Clark Adrian , Storr Helen

Introduction: Triple A syndrome is a rare, autosomal recessive cause of adrenal failure that usually manifests in the first decade. Most cases have isolated glucocorticoid deficiency, but this is accompanied by mineralocorticoid deficiency in ~10%. Additional features include alacrima (~90%), achalasia of the oesophageal cardia (~75%), and a progressive neurodegenerative process (~60%). The AAAS gene product is the nuclear pore complex protein ALADIN of unknown function...

ea0066oc4.5 | Oral Communications 4 | BSPED2019

Novel genetic defects in a cohort of Silver–Russell Syndrome (SRS) and SRS-like patients

Cottrell Emily , Ishida Miho , Moore Gudrun , Storr Helen L

Background: Silver-Russell Syndrome (SRS) is a clinically and genetically heterogenous condition. 40% patients with ‘clinical’ SRS remain without a genetic diagnosis despite fulfilling the Netchine-Harbison Clinical Scoring System (NH-CSS) criteria. There is increasing recognition of the wide range of clinical phenotypes within the SRS spectrum and overlap with other short stature syndromes.Methods: We analysed 26 undiagnosed patients with feat...

ea0039oc5.2 | Oral Communications 5 | BSPED2015

Genetic characterisation of children with short stature and GH or IGF1 insensitivity by single gene and whole exome sequencing

Shapiro Lucy , Savage Martin , Metherell Lou , Storr Helen

Background: GH insensitivity (GHI) encompasses growth failure, low serum IGF1 and normal/elevated serum GH. IGF1 insensitivity results in pre- and postnatal growth failure with normal/relatively high IGF1 levels.Objective: To undertake candidate gene (CGS) and whole exome (WES) sequencing to obtain a genetic diagnosis in children with short stature and GHI or IGF1 insensitivity.Methods: As a referral centre for GHI genetics, since ...

ea0038p154 | Neoplasia, cancer and late effects | SFEBES2015

Adrenal pigmentation in PPNAD is a result of melanin deposition and associated with upregulation of the melanocortin 1 receptor

Cavlan Dominic , Storr Helen , Berney Dan , Evagora Chris , King Peter

Primary pigmented nodular adrenal disease (PPNAD) is a form of bilateral adrenocortical hyperplasia characterised by small to normal sized adrenal glands containing multiple small cortical pigmented nodules1. It may occur independently, but 90% of cases are a manifestation of the Carney complex. Most cases of PPNAD are diagnosed before age 30, and are the result of a germline mutation in PRKAR1A or PDE11A, leading to upregulation of cAMP signalling. It is a cause of...

ea0025p207 | Growth and development | SFEBES2011

Genetic characterisation of primary GH Insensitivity (GHI) presenting as growth failure: 10 years experience at the Centre for Endocrinology, William Harvey Research Institute, Barts and the London

Metherell Louise , David Alessia , Savage Martin , Clark Adrian , Storr Helen

GHI is a genetic condition in which patients present with growth failure due to primary IGF1 deficiency caused by a defect in the GH-IGF1 axis. In the last 10 years in the Centre for Endocrinology of WHRI at Barts and the London, 24 causative mutations in genes of the GH–IGF1 axis have been determined in 58 patients (Table 1). STAT5B mutations were responsible in 2 cases, IGFALS in 4 but the majority of defects identified were in GHR. Most mutations identifi...